Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of Tuesday, October 6, 2026.
RETURN ON EQUITY (ROE)
N/A
Thunder Bridge Capital Partners V L
Market Cap
$266.29M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.50M
Return on Equity (ROE)
3.70%
TTM Avg
1.79%
3Y Avg
104.71%
5Y Avg
104.71%
Market Cap
$265.95M
Return on Equity (ROE)
14.45%
TTM Avg
12.94%
3Y Avg
10.71%
5Y Avg
11.49%
Market Cap
$267.82M
Return on Equity (ROE)
0.03%
TTM Avg
30.37%
3Y Avg
-4.86%
5Y Avg
-4.69%
Market Cap
$264.51M
Return on Equity (ROE)
3.41%
TTM Avg
1.87%
3Y Avg
1.87%
5Y Avg
1.87%
Market Cap
$264.47M
Return on Equity (ROE)
3.49%
TTM Avg
2.30%
3Y Avg
2.30%
5Y Avg
2.30%
Market Cap
$264.38M
Return on Equity (ROE)
4.42%
TTM Avg
99.43%
3Y Avg
99.43%
5Y Avg
99.43%
Market Cap
$268.25M
Return on Equity (ROE)
8.74%
TTM Avg
6.88%
3Y Avg
7.54%
5Y Avg
7.88%
Market Cap
$263.53M
Return on Equity (ROE)
183.78%
TTM Avg
142.95%
3Y Avg
142.95%
5Y Avg
142.95%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thunder Bridge Capital Partners V L (TBCVU) | $266.29M | N/A | N/A | N/A | N/A |
| Translational Development Acquisition Corp. (TDAC)vs › | $266.50M | 3.70% | 1.79% | 104.71% | 104.71% |
| Hawthorn Bancshares, Inc. (HWBK)vs › | $265.95M | 14.45% | 12.94% | 10.71% | 11.49% |
| Kingstone Companies, Inc. (KINS)vs › | $267.82M | 0.03% | 30.37% | -4.86% | -4.69% |
| Oaktree Acquisition Corp. II (OACC)vs › | $264.51M | 3.41% | 1.87% | 1.87% | 1.87% |
| ProCap Acquisition Corp (PCAP)vs › | $264.47M | 3.49% | 2.30% | 2.30% | 2.30% |
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs › | $264.38M | 4.42% | 99.43% | 99.43% | 99.43% |
| LCNB Corp. (LCNB)vs › | $268.25M | 8.74% | 6.88% | 7.54% | 7.88% |
| Soren Acquisition Corp. (SORN)vs › | $263.53M | 183.78% | 142.95% | 142.95% | 142.95% |
| Cartesian Growth Corp. Iv (CGCF)vs › | $270.05M | N/A | N/A | N/A | N/A |
ROE
N/A
ROA
N/A
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
